How does this ingredient formulary business work?
International Flavors & Fragrances Inc formulates ingredients used in consumer and industrial products, spanning flavors and fragrances alongside related specialty ingredients. Its products are typically embedded in customers’ finished goods rather than sold as end-consumer brands. The business model centers on formulation know-how and long-lived customer relationships tied to product performance and consistency. At today’s scale, it sits as a large public chemicals business by market value, with a market cap of USD 19.4 billion.
Are margins holding up despite weak earnings?
FundamentalsFor 2025, reported in USD, revenue was USD 10.9 billion, down 5.2% year over year, while net income was only USD 2.0 million. Trailing margins remain meaningfully positive at the operating line, with a 36.35% gross margin and an 11.09% operating margin, alongside a 7.90% net margin on a TTM basis.
Capital intensity shows up in the fixed-charge lines: depreciation and amortization ran at USD 962.0 million, with capital spending of USD 594.0 million. Total debt was USD 2.5 billion. On the returns angle, the trailing ROE of 5.99% frames a business that is currently converting its capital base into modest shareholder returns.
Does the price reflect a recovery?
DCF / MultiplesAt USD 75.94, the stock sits below the DCF-based value range from a weaker scenario to a stronger outcome. Headline pricing sits around 22.76x trailing earnings and 13.95x EV/EBITDA.
A recovery-driven valuation case
TakeawayThe valuation case depends on returns on capital improving. Margins look healthy, but reported earnings did not follow. Debt makes the cost of a slow recovery higher. If profits normalize, the current price has room to work. If earnings stay thin, the multiple will be hard to defend.
